Piperine potentiates the hypocholesterolemic effect of curcumin in rats fed on a high fat diet

Experimental and Therapeutic Medicine

Volumn 8, Issue 1, 2014, Pages 260-266

  Tu, Yao Sheng ^a   Sun, Dong Mei ^a   Zeng, Xiao Hui ^a   Yao, Nan ^a   Huang, Xue Jun ^a   Huang, Dane ^a   Chen, Yu Xing ^a  

^a Guangdong Provincial Institute of Traditional Chinese Medicine   (China)

Author keywords

Cholesterol; Curcumin; MRNA; Piperine; Rat

Indexed keywords

APOLIPOPROTEIN A1; BILE ACID; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CURCUMIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PIPERINE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG POTENTIATION; FECES ANALYSIS; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOCHOLESTEROLEMIA; LIPID DIET; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RAT; UPREGULATION;

EID: 84901358407     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1717     Document Type: Article

References (43)

1. Assmann G, Cullen P, Jossa F, Lewis B and Mancini M: Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart disease. Arterioscler Thromb Vasc Biol 19: 1819-1824, 1999.
2. Asai A and Miyazawa T: Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr 131: 2932-2935, 2001.
3. Aggarwal BB, Kumar A and Bharti AC: Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23: 363-398, 2003.
4. Holt PR, Katz S and Kirshoff R: Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci 50: 2191-2193, 2005.
5. Shehzad A, Ha T, Subhan F and Lee YS: New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur J Nutr 50: 151-161, 2011.
6. Killian PH, Kronski E, Michalik KM, et al: Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2. Carcinogenesis 33: 2507-2519, 2012.
7. Sadzuka Y, Nagamine M, Toyooka T, Ibuki Y and Sonobe T: Beneficial effects of curcumin on antitumor activity and adverse reactions of doxorubicin. Int J Pharm 432: 42-49, 2012.
8. Sahin K, Orhan C, Tuzcu Z, Tuzcu M and Sahin N: Curcumin ameloriates heat stress via inhibition of oxidative stress and modulation of Nrf2/HO-1 pathway in quail. Food Chem Toxicol 50: 4035-4041, 2012.
9. Meng B, Li J and Cao H: Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications. Curr Pharm Des 19: 2101-2113, 2013.
10. Shehzad A, Rehman G and Lee YS: Curcumin in inflammatory diseases. Biofactors 39: 69-77, 2013.
11. Tokaç M, Taner G, Aydin S, et al: Protective effects of curcumin against oxidative stress parameters and DNA damage in the livers and kidneys of rats with biliary obstruction. Food Chem Toxicol 61: 28-35, 2013.
12. Arafa HM: Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit 11: BR228-BR234, 2005.
13. Manjunatha H and Srinivasan K: Hypolipidemic and antioxidant effects of dietary curcumin and capsaicin in induced hypercholesterolemic rats. Lipids 42: 1133-1142, 2007.
14. Jang EM, Choi MS, Jung UJ, et al: Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters. Metabolism 57: 1576-1583, 2008.
15. Kapoor P, Ansari MN and Bhandari U: Modulatory effect of curcumin on methionine-induced hyperlipidemia and hyperhomocysteinemia in albino rats. Indian J Exp Biol 46: 534-540, 2008.
16. Kim M and Kim Y: Hypocholesterolemic effects of curcumin via up-regulation of cholesterol 7a-hydroxylase in rats fed a high fat diet. Nutr Res Pract 4: 191-195, 2010.
17. Anand P, Kunnumakkara AB, Newman RA and Aggarwal BB: Bioavailability of curcumin: problems and promises. Mol Pharm 4: 807-818, 2007.
18. Srinivasan K: Black pepper and its pungent principle-piperine: a review of diverse physiological effects. Crit Rev Food Sci Nutr 47: 735-748, 2007.
19. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R and Srinivas PS: Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64: 353-356, 1998.
20. Suresh D and Srinivasan K: Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats. Indian J Med Res 131: 682-691, 2010.
21. Bhutani MK, Bishnoi M and Kulkarni SK: Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacol Biochem Behav 92: 39-43, 2009.
22. Rinwa P and Kumar A: Piperine potentiates the protective effects of curcumin against chronic unpredictable stress-induced cognitive impairment and oxidative damage in mice. Brain Res 1488: 38-50, 2012.
23. Sehgal A, Kumar M, Jain M and Dhawan DK: Piperine as an adjuvant increases the efficacy of curcumin in mitigating benzo(a)pyrene toxicity. Hum Exp Toxicol 31: 473-482, 2012.
24. Kaur G and C M: Amelioration of obesity, glucose intolerance, and oxidative stress in high-fat diet and low-dose streptozotocin-induced diabetic rats by combination consisting of 'curcumin with piperine and quercetin'. ISRN Pharmacol 2012: 957283, 2012.
25. Feldmann D, Fenech C and Cuer JF: Evaluation of a sample-preparation procedure for bile acids in serum and bile. Clin Chem 29: 1694, 1983.
26. Gong J, Peng C, Chen T, Gao B and Zhou H: Effects of theabrownin from pu-erh tea on the metabolism of serum lipids in rats: mechanism of action. J Food Sci 75: H182-H189, 2010.
27. Kleinsek DA, Ranganathan S and Porter JW: Purification of 3-hydroxy-3-methylglutaryl-coenzyme A reductase from rat liver. Proc Natl Acad Sci USA 74: 1431-1435, 1977.
28. Yamazaki H, Inoue K, Turvy CG, Guengerich FP and Shimada T: Effects of freezing, thawing, and storage of human liver samples on the microsomal contents and activities of cytochrome P450 enzymes. Drug Metab Dispos 25: 168-174, 1997.
29. Honda A, Salen G, Matsuzaki Y, et al: Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX. J Lipid Res 42: 291-300, 2001.
30. Hylemon PB, Studer EJ, Pandak WM, Heuman DM, Vlahcevic ZR and Chiang JY: Simultaneous measurement of cholesterol 7 alpha-hydroxylase activity by reverse-phase high-performance liquid chromatography using both endogenous and exogenous [4-14C]cholesterol as substrate. Anal Biochem 182: 212-216, 1989.
31. Zannis VI, Chroni A, Kypreos KE, et al: Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer. Curr Opin Lipidol 15: 151-166, 2004.
32. Krieger M: Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. J Clin Invest 108: 793-797, 2001.
33. Hoeg JM, Santamarina-Fojo S, Bérard AM, et al: Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc Natl Acad Sci USA 93: 11448-11453, 1996.
34. Brousseau ME, Santamarina-Fojo S, Vaisman BL, et al: Overexpression of human lecithin:cholesterol acyltransferase in cholesterol-fed rabbits: LDL metabolism and HDL metabolism are affected in a gene dose-dependent manner. J Lipid Res 38: 2537-2547, 1997.
35. Aizawa K and Inakuma T: Dietary capsanthin, the main carotenoid in paprika (Capsicum annuum), alters plasma high-density lipoprotein-cholesterol levels and hepatic gene expression in rats. Br J Nutr 102: 1760-1766, 2009.
36. Zhang Z, Wang H, Jiao R, et al: Choosing hamsters but not rats as a model for studying plasma cholesterol-lowering activity of functional foods. Mol Nut Food Res 53: 921-930, 2009.
37. Kuwabara T, Han KH, Hashimoto N, et al: Tartary buckwheat sprout powder lowers plasma cholesterol level in rats. J Nutr Scie Vitaminol (Tokyo) 53: 501-507, 2007.
38. Russell DW and Setchell KD: Bile acid biosynthesis. Biochemistry 31: 4737-4749, 1992.
39. Yiu WF, Kwan PL, Wong CY, et al: Attenuation of fatty liver and prevention of hypercholesterolemia by extract of Curcuma longa through regulating the expression of CYP7A1, LDL-receptor, HO-1, and HMG-CoA reductase. J Food Sci 76: H80-H89, 2011.
40. Rao DS, Sekhara NC, Satyanarayana MN and Srinivasan M: Effect of curcumin on serum and liver cholesterol levels in the rat. J Nutr 100: 1307-1315, 1970.
41. Goldstein JL and Brown MS: Regulation of the mevalonate pathway. Nature 343: 425-430, 1990.
42. Peschel D, Koerting R and Nass N: Curcumin induces changes in expression of genes involved in cholesterol homeostasis. J Nutr Biochem 18: 113-119, 2007.
43. Dou X, Fan C, Wo L, Yan J, Qian Y and Wo X: Curcumin up-regulates LDL receptor expression via the sterol regulatory element pathway in HepG2 cells. Planta medica 74: 1374-1379, 2008.